Glaxo SmithKline (BIOC)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Insider Trades
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

{{ 'components.chart.period.' + period | translate }}

{{ 'components.chart.type.' + type | translate }}

This mark means that there are news on this date.

Stock

Par Value 10.00 Egyptian Pound

Market Cap 2,325,035,328.00 Egyptian Pound

Book Value (BVPS) 23.53 Egyptian Pound Based on: Fourth Quarter 2023

P/B Ratio 1.54 Last update: 2019-03-31

EPS 0.65 Egyptian Pound Based on: Fourth Quarter 2023

P/E Ratio 18.70 Last update: 2019-03-31

Trading Currency Egyptian Pound

Company Statistics

News

GSK Egypt obtains shareholders’ nod for 2023 cash dividends Cash Dividends

GSK Egypt’s consolidated profits plunge to EGP 60m in 2023; dividends approved Financial Results

GSK Egypt records plunge in 9M-23 profits; sales hit EGP 1.57bn Financial Results

GSK Egypt’s net profits shrink in H1-23 results Financial Results

GSK Egypt generates lower consolidated profits in Q1-23 Financial Results

GSK Egypt’s shareholders approve 2022 cash dividends Cash Dividends

Market Announcements